Coverage
-
June 10, 2022
A California judge gave a final toss to investor litigation accusing GoodRx of inflating the health care technology company's initial public offering stock price by hiding news of a rival Amazon program in the works, saying Thursday a revised complaint still lacked facts showing the defendants knew of the competitor's plans.
1 other articles on this case.
View all »